SEARCH RESULTS

1567 RESULTS

Dipraglurant

THERAPEUTICS 6-Fluoro-2-[4-(2-pyridinyl)-3-butyn-1-yl]imidazo[1,2-a]pyridine Addex Therapeutics ADX48621 Small Molecule Other Neurotransmitters Addex completed a Phase 2a trial for Parkinson’s Disease LID in 2012. Conducted in the U.S. and Europe, it enrolled 76 peopl

J.P.H. Burbach


University Medical Center Utrecht
Utrecht, Netherlands

Sopan Nangare


Research Scholar, ICMR, India
Shirpur, Dhule, India

Ozgun Gokce


Klinikum der Universität München
Germany

Current Filters

  • Date Range : Feb 2021 to Mar 2021 x

Remove all filters

Filter By

DATE RANGE
  • All
  • Past 7 Days
  • Past 30 Days
  • Past 90 Days
  • Past 12 Months
  • Specific Dates
    1. From
      To

TYPE